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Learning Objectives
• To introduce you to some new approaches to chronic pain that you may not be currently using • To review the indications for buprenorphine for chronic pain therapy • To review best practice for patients with chronic pain and an opioid use disorder • Lightning round of pearls based on questions I often get Learning Method • LH is a 56yo M with obesity, schizophrenia, OUD on MMT, and chronic LBP presenting for f/u. He has a spine MRI showing lumbar DJD.
• He has tried the following:
• PT -didn't like it bc it caused pain • NSAIDs -inadequate effect, creat bumped • Gabapentin -caused excess sedation • Topical agents: capsaicin cream, topical lidocaine, mentholated cream
• His perspective:
• "This pain is killing me, doc. You've gotta do something for me. It goes back and forth across my lower back, and it's horrible"
Case 1
• What would you offer this patient?
• 1) refer for epidural spinal injection • 2) start oxycodone • 3) paraspinous lidocaine injection • 4) testosterone injection
• 1) refer for epidural spinal injection • 2) start oxycodone • 3) paraspinous lidocaine injection Case 2 • JM is a 63yo F with OUD on bupe-nal, scoliosis, chronic low back pain, COPD on chronic oxygen, uses a walker for ambulation complaining of ongoing back pain.
• Non-focal neuro exam and MRI stable
• Prescribed the following:
• She asks: "what about a muscle relaxant?"
Question
• Which of the following is true about muscle relaxants in chronic pain?
• A) Tizanidine is dosed 1 mg q day • B) Evidence suggests a benefit only with short term use • C) Use is associated with QTc prolongation • D) Adding them to an NSAID confers no additional benefit
Case 2: Muscle relaxants in back pain
• Commonly used muscle relaxants in the US:
• (carisoprodol and BZDs) -discouraged given abuse liability
• Evidence-base
• Meta-analyses of muscle relaxants: 5 high quality trials (496 participants)
• Head-to-head trials of muscle relaxants Case 3
• GM is 43 and has hx of cocaine UD, low back pain, nicotine use disorder and depression.
• He is complaining of chronic pain and requesting oxy-APAP as he says this works the best for him? • You're wondering if you can just give him buprenorphine and call it a day.
• Which of the following is true of buprenorphine for chronic pain? • Effectiveness:
• Decrease mean pain scores 2.3/10 points • Patch equivalent to SL buprnoprhine
Buprenorphine and OUD
• Formulations
• Sublingual film (Suboxone)
• Sublingual tab (bupe-naloxone, Zubsolv)
• SC injection (Sublocade; 4 weeks)
• DOSAGES ARE HIGHER
• Standard dose for a patient with OUD: 8-24mg/day
• Strength of buprenorphine
• 30x stronger than morphing (estimate)
Back to our patient
• What does this history tell us? Is he at risk for having problems with COT?
Risk Assessment Tool
• Opioid Risk Tool (ORT)
• 5-item initial risk assessment • Stratifies risk into low (6%), moderate (28%) and high (91%) What about people on COT switching to buprenorphine?
• Reasons to switch 
Tapering in Patients with Prescription OUD
• Standard of care for OUD: maintenance treatment
• Increased relapse and death for patients leaving program
• Prescription opioid use disorders:
• Superior outcomes with buprenorphine-naloxone maintenance compared to detoxification Case 4
• KD is a 40yo F with a hx of chronic ileocolonic Crohn's disease s/p ileal cecectomy c/b perforation s/p ileostomy and R hemicolectomy with subsequent takedown, immunosuppression, s/p chole, depression, fibromyalgia, and chronic abdominal pain presenting for nausea, vomiting and abdominal pain. Due to nutritional failure, she had a GJ tube placed for supplemental nutrition.
• She has had multiple trips to the hospital and emergency department for similar complaints (>6 visits in the past 3 months). She is on vedolizumab with good response (repeat colonoscopies demonstrating no active disease). During her multiple admissions, she has had normal inflammatory markers and no evidence of infection. Her last admission included starting TPN for nutritional support because any trial of PO/TF nutrition led to pain.
Case continued
• Previous admission teams have concluded that after extensive work-up, the cause of her pain is visceral hyperalgesia, functional abdominal pain, and some psychogenic component.
• She returns back to the hospital with abdominal pain and report of loose stools from her tube feeds.
• Her meds include:
• Oxycodone ER 30mg BID • Oxycodone IR 30mg 1 tab TID prn pain
• MME 225mg daily • She denies any tobacco, alcohol, or illicit drug use.
• Labs are notable for: stable anemia, normal renal function, utox +oxy
• The patient expressed concern over her continued health problems. She says that she is frustrated that she is continually in the hospital. She said that she tried to stay at home, but could not tolerate the pain.
• When asked how things are going with the pain medication, she says that she has wanted to not be on the medicine, but whenever she tries to not take it, she feels worse. Several months ago she voluntarily decreased the dose of her opioids with her primary care provider. She feels like her life revolves around her health conditions and pain. She wishes she could "be normal again." Her pain & health needs creates problems w/her mom and dad (and her) because they don't understand why she's still so bad off. She has a degree in psychology, but hasn't worked for several years.
Question
• Which of the following would be your next step in her management?
• 4Rs
• Risk of bodily harm a One or more abuse criteria within a 12-month period and no dependence diagnosis; applicable to all substances except nicotine, for which DSM-IV abuse criteria were not given. b Three or more dependence criteria within a 12-month period. c Two or more substance use disorder criteria within a 12-month period. d Withdrawal not included for cannabis, inhalant, and hallucinogen disorders in DSM-IV. Cannabis withdrawal added in DSM-5. 
Loss of

Case continued
• When asked how things are going with the pain medication, she says that she has wanted to not be on the medicine, but whenever she tries to not take it, she feels worse. Several months ago she voluntarily decreased the dose of her opioids with her primary care provider. She feels like her life revolves around her health conditions and pain. She wishes she could "be normal again." Her pain & health needs creates problems w/her mom and dad (and her) because they don't understand why she's still so bad off. She has a degree in psychology, but hasn't worked for several years. 
Language & Communication is Everything
• How are things going with your opioid medicine(s)?
• That sounds really hard to feel like you're only getting partial relief.
• Have you ever wished you never started the meds? Have you ever wished you were off of them?
• That's impressive that you've even contemplated a world with out pills.
• You know some patients I work with tell me that they're frustrated with having to always keep up with their pain with the pills, and it's exhausting. They feel like their days revolve around the pain meds. Has that ever happened to you?
• That sounds tough. You obviously have taken a lot of care to keep yourself as well as can be.
• Do you ever think the meds might be in control of you? Like you can't do the things you want or be the person you want to be because you're dealing with your pain meds?
• You're obviously someone who has suffered a lot and overcome a huge amount.
Question
• Which of the following would be your next step in her management (in the hospital)?
Has an OUD; transition to maintenance treatment Case Continued
• After checking labs and urine drug screen, we stopped the patient's long-acting and short-acting opioids. She developed symptoms of withdrawal.
• We informed her in advance she would have to go 12-16 hours without the oxycodone.
• We gave her medication to help with her symptoms:
• Ondansetron 4mg PO q6hrs PRN nausea • Diphenhydramine 25-50mg PO q8hrs PRN insomnia/anxiety • Clonidine 0.1-0.3mg PO q6-8hrs PRN agitation from w/d • Others (see SHOUT guide)
• We calculated a COWS score
Case Continued
• After 16 hours, she got her first dose of 4mg and did not develop worsening withdrawal symptoms.
• She got another 4mg after 1 hr • She got another 4mg after 1hr
• 4 hrs later she got one more 4mg dose • Total 16mg on the first day
• The next day she got 8mg in the morning, and 8mg at night • We gave her A LOT of praise for undergoing the induction
• The patient ultimately required 24mg daily of buprenorphinenaloxone, split TID • She was discharged back to follow-up with her primary care providers
• Unfortunately her PCP did not have an x-license, so she had to be seen by another provider • The new provider didin't think the patient had an OUD and prescribed the buprenorphine mono product (instead of bupe-nal). This required a prior authorization for Medical. The dose was also reduced to 4mg TID (instead of 8mg TID) • The prior authorization was not approved the same day and the patient had returned to the emergency department.
Lightning Round
• "If I take my patients off opioids, can I just put them on tramadol?"
Tramadol
• Schedule 4 (not schedule 2; max 5 refills/6mo); happened in 2014 • MOA:
• Mu opioid receptor agonist • NE and 5HT reuptake inhibitor (avoid with MAOIs and TCAs) -can cause serotonin syndrome • PK: has active metabolite (M1; CYP 2D6) with higher affinity for mu receptor. T1/2 5hr, 9hr (M1)
• Medicare requests you trial this before bupe • Abuse liability?
Abuse Liability of Tramadol
• Surgical literature (Mayo)
• 444,764 patients post-op, analyzed claims data
• 357,884 filled rx for opioids (50% HC, ~40% oxy, 4% tramadol)post-op
• 7% had at least 1 REFILL 90-180 days after surgery (additional use) • 1% refilled 180-270 days (persistent use) • 0.5% 10 or more rxs (long-term use) • All 3 of these groups were more likely to have received tramadol (~40% incrase risk fo persistent/chronic use)
• Observation studies in countries with rx not required
• Egypt -~10% with OUD; ~>50% using tramadol • Iran -survey of customers -60% reporting addiction sxs 
